GS-441524 prodrug
- Generic Name
- GS-441524 prodrug
Oral Antiviral Obeldesivir Shows Promise in Treating Ebola Virus in Primate Study
• A groundbreaking study led by University of Texas researchers demonstrates that Obeldesivir, an oral form of Remdesivir, successfully protected monkeys infected with high doses of the Ebola virus.
• The pill protected 80% of cynomolgus macaques and 100% of rhesus macaques from the deadly Makona variant of Ebola, potentially offering a practical alternative to antibody treatments that require cold storage.
• Based on these promising results, pharmaceutical company Gilead has advanced Obeldesivir to Phase 2 clinical trials for Marburg virus, suggesting broader applications for treating deadly hemorrhagic fevers.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath